{"id":4447,"date":"2018-06-16T10:05:48","date_gmt":"2018-06-16T14:05:48","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=4447"},"modified":"2018-06-16T10:05:48","modified_gmt":"2018-06-16T14:05:48","slug":"ipo-pipeline-update-6-15-18","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-pipeline-update-6-15-18\/","title":{"rendered":"IPO Pipeline Update (6.15.18)"},"content":{"rendered":"<p>IPO Boutique keeps apprised of the active pipeline. Currently there are 72 active IPOs in the pipeline as of June 15, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why \u201clooks may be perceiving\u201d when it comes to the IPO pipeline\u00a0<a href=\"http:\/\/www.ipoboutique.com\/blog\/?p=2877\" target=\"_blank\"><strong>in this article.<\/strong><\/a><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/Screen-Shot-2018-06-16-at-10.05.32-AM.png\"><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter size-full wp-image-4448\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/Screen-Shot-2018-06-16-at-10.05.32-AM.png\" alt=\"Screen Shot 2018-06-16 at 10.05.32 AM\" width=\"1064\" height=\"371\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/Screen-Shot-2018-06-16-at-10.05.32-AM.png 1064w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/Screen-Shot-2018-06-16-at-10.05.32-AM-600x209.png 600w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/Screen-Shot-2018-06-16-at-10.05.32-AM-300x105.png 300w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/Screen-Shot-2018-06-16-at-10.05.32-AM-1024x357.png 1024w\" sizes=\"(max-width: 1064px) 100vw, 1064px\" \/><\/a><\/p>\n<p><span style=\"text-decoration: underline;\"><strong>NEW FILINGS<\/strong><\/span><\/p>\n<p>Company: Navios Maritime Containers L.P.<br \/>\nSymbol: TBD<br \/>\nDescription: They are a growth-oriented international owner and operator of containerships.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s): J.P. Morgan, BofA Merrill Lynch, Citigroup, Clarksons Platou Securities<br \/>\nCo-Manager(s): S. Goldman Advisors LLC<br \/>\nFiled: 6-15-18<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Bloom Energy Corporation<br \/>\nSymbol: BE<br \/>\nDescription: Their mission is to make clean, reliable, and affordable energy for everyone in the world.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s): J.P. Morgan, Morgan Stanley, Credit Suisse, KeyBanc Capital, BofA Merrill Lynch<br \/>\nCo-Manager(s): Baird, Cowen, HSBC, Oppenheimer &amp; Co., Raymond James<br \/>\nFiled: 6-12-18<br \/>\nListed Cash Raise: $100m<\/p>\n<p><span style=\"text-decoration: underline;\"><strong>TERMS ADDED<\/strong><\/span><\/p>\n<p>Company: Aptinyx, Inc.<br \/>\nSymbol: APTX<br \/>\nDescription: They are a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel, proprietary, synthetic small molecules for the treatment of brain and nervous system disorders.<br \/>\nTrade Date: 6\/21<br \/>\nShares: 5.33 million<br \/>\nPrice Range: $14.00-$16.00<br \/>\nUnderwriter(s): J.P. Morgan, Cowen, Leerink Partners, BMO Capital Markets<br \/>\nTerms Added: 6-11-18<\/p>\n<p>Company: AVROBIO, Inc.<br \/>\nSymbol: AVRO<br \/>\nDescription: They are a clinical stage gene therapy company focused on developing potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose.<br \/>\nTrade Date: 6\/21<br \/>\nShares: 4.4 million<br \/>\nPrice Range: $16.00-$18.00<br \/>\nUnderwriter(s): Morgan Stanley, Cowen, Wells Fargo Securities<br \/>\nCo-Manager(s): Wedbush Pacgrow<br \/>\nTerms Added: 6-11-18<\/p>\n<p>Company: Essential Properties Realty Trust, Inc.<br \/>\nSymbol: EPRT<br \/>\nDescription: They are an internally managed real estate company that acquires, owns and manages primarily single-tenant properties that are net leased on a long-term basis to middle-market companies operating service-oriented or experience-based businesses.<br \/>\nTrade Date: 6\/21<br \/>\nShares: 32.5 million<br \/>\nPrice Range: $14.00-$17.00<br \/>\nUnderwriter(s): Goldman Sachs, Citigroup, Barclays, BofA Merrill Lynch, Credit Suisse<br \/>\nCo-Manager: RBC Capital, SunTrust Robinson, Evercore ISI, Ladenburg Thalmann<br \/>\nTerms Added: 6-11-18<\/p>\n<p>Company: i3 Verticals, Inc.<br \/>\nSymbol: IIIV<br \/>\nDescription: They deliver seamless integrated payment and software solutions to small- and medium-sized businesses and organizations in strategic vertical markets.<br \/>\nTrade Date: 6\/21<br \/>\nShares: 6.65 million<br \/>\nPrice Range: $11.00-$13.00<br \/>\nUnderwriter(s): Cowen, Raymond James, KeyBanc Capital Markets<br \/>\nTerms Added: 6-11-18<\/p>\n<p>Company: Xeris Pharmaceuticals, Inc.<br \/>\nSymbol: XERS<br \/>\nDescription: They are a specialty pharmaceutical company leveraging our novel non-aqueous formulation technology platforms, XeriSol and XeriJect, to develop and commercialize ready-to-use injectable and infusible drug formulations.<br \/>\nTrade Date: 6\/21<br \/>\nShares: 5 million<br \/>\nPrice Range: $14.00-$16.00<br \/>\nUnderwriter(s): Jefferies, Leerink Partners, RBC Capital, Mizuho Securities<br \/>\nTerms Added: 6-11-18<\/p>\n<p>Company: Uxin Limited<br \/>\nSymbol: UXIN<br \/>\nDescription: They are the largest used car e-commerce platform in China in terms of both the number of transactions facilitated and total GMV in 2017, according to iResearch.<br \/>\nTrade Date: 6\/27<br \/>\nShares: 38 million ADS<br \/>\nPrice Range: $10.50-$12.50<br \/>\nUnderwriter(s): Morgan Stanley, Goldman Sachs (Asia) LLC, J.P. Morgan, CICC, China Renaissance<br \/>\nTerms Added: 6-13-18<\/p>\n<p>Company: Neon Therapeutics<br \/>\nSymbol: NTGN<br \/>\nDescription: They are a clinical-stage immuno-oncology company and a leader in the field of neoantigen-targeted therapies, dedicated to transforming the treatment of cancer by directing the immune system towards neoantigens<br \/>\nTrade Date: 6\/27<br \/>\nShares: 6.25 million<br \/>\nPrice Range: $15.00-$17.00<br \/>\nUnderwriter(s): Morgan Stanley, BofA Merrill Lynch, Mizuho Securities<br \/>\nCo-Manager(s): Oppenheimer &amp; Co.<br \/>\nTerms Added: 6-15-18<\/p>\n<p>Company: Neuronetics, Inc.<br \/>\nSymbol: STIM<br \/>\nDescription: They are a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorder<br \/>\nTrade Date: 6\/28<br \/>\nShares: 5 million<br \/>\nPrice Range: $14.00-$16.00<br \/>\nUnderwriter(s): Piper Jaffray, William Blair<br \/>\nCo-Manager(s): Canaccord Genuity, BTIG, JMP Securities<br \/>\nTerms Added: 6-15-18<\/p>\n","protected":false},"excerpt":{"rendered":"<p>IPO Boutique keeps apprised of the active pipeline. Currently there are 72 active IPOs in the pipeline as of June 15, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why \u201clooks may be perceiving\u201d when it comes to the IPO pipeline\u00a0in this article. NEW FILINGS Company: Navios[&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[1],"tags":[],"class_list":["post-4447","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/4447","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=4447"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/4447\/revisions"}],"predecessor-version":[{"id":4449,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/4447\/revisions\/4449"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=4447"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=4447"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=4447"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}